Advertisement
Screener

Vaccinex, Inc. (VCNX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.8 / 5 stars · 68/120 Roast Me

Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 15.78 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-04-15

  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 11.94K shares.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 3.10K shares.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 183.00 shares.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 565.00 shares, a 82.27% decline year-over-year.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 15.78K shares, a 8295.74% increase from fiscal 2023.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 188.00 shares, a 208.20% increase from fiscal 2022.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 61.00 shares, a 99.76% decline from fiscal 2021.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 25.25K shares, a 65.85% decline from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2024-12-3111.94K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
15.04K shares
derived: sum of 2 quarters · filed 2025-04-15
15.22K shares
derived: sum of 3 quarters · filed 2025-04-15
15.78K shares
10-K · filed 2025-04-15
2024-09-303.10K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
3.28K shares
derived: sum of 2 quarters · filed 2024-11-14
3.85K shares
10-Q · filed 2024-11-14
3.82K shares
derived: sum of 4 quarters · filed 2025-04-15
2024-06-30183.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
748.00 shares
10-Q · filed 2024-08-14
725.00 shares
derived: sum of 3 quarters · filed 2025-04-15
-2.25K shares
derived: sum of 4 quarters · filed 2025-04-15
2024-03-31565.00 shares
10-Q · filed 2024-05-15
542.00 shares
derived: sum of 2 quarters · filed 2025-04-15
-2.43K shares
derived: sum of 3 quarters · filed 2025-04-15
-2.43K shares
derived: sum of 4 quarters · filed 2025-04-15
2023-12-31-23.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-3.00K shares
derived: sum of 2 quarters · filed 2025-04-15
-3.00K shares
derived: sum of 3 quarters · filed 2025-04-15
188.00 shares
10-K · filed 2025-04-15
2023-09-30-2.98K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-2.98K shares
derived: sum of 2 quarters · filed 2023-11-13
211.00 shares
10-Q · filed 2023-11-13
-5.86K shares
derived: sum of 4 quarters · filed 2024-04-25
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
3.19K shares
10-Q · filed 2023-08-14
-2.89K shares
derived: sum of 3 quarters · filed 2024-04-25
-2.89K shares
derived: sum of 4 quarters · filed 2024-04-25
2023-03-313.19K shares
10-Q · filed 2023-05-15
-2.89K shares
derived: sum of 2 quarters · filed 2024-04-25
-2.89K shares
derived: sum of 3 quarters · filed 2024-04-25
-2.00 shares
derived: sum of 4 quarters · filed 2024-04-25
2022-12-31-6.07K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25
-6.07K shares
derived: sum of 2 quarters · filed 2024-04-25
-3.19K shares
derived: sum of 3 quarters · filed 2024-04-25
61.00 shares
10-K/A · filed 2024-04-25
12.95K shares
10-K · filed 2023-03-31
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
2.88K shares
derived: sum of 2 quarters · filed 2022-11-14
6.13K shares
10-Q · filed 2022-11-14
11.88K shares
derived: sum of 4 quarters · filed 2023-03-31
2022-06-302.88K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
6.13K shares
10-Q · filed 2022-08-15
11.88K shares
derived: sum of 3 quarters · filed 2023-03-31
8.88K shares
derived: sum of 4 quarters · filed 2023-03-31
2022-03-313.25K shares
10-Q · filed 2022-05-16
9.00K shares
derived: sum of 2 quarters · filed 2023-03-31
6.00K shares
derived: sum of 3 quarters · filed 2023-03-31
12.75K shares
derived: sum of 4 quarters · filed 2023-03-31
2021-12-315.75K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
2.75K shares
derived: sum of 2 quarters · filed 2023-03-31
9.50K shares
derived: sum of 3 quarters · filed 2023-03-31
25.25K shares
10-K · filed 2023-03-31
2021-09-30-3.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
3.75K shares
derived: sum of 2 quarters · filed 2021-11-08
19.50K shares
10-Q · filed 2021-11-08
84.92K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-06-306.75K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
22.50K shares
10-Q · filed 2021-08-16
87.92K shares
derived: sum of 3 quarters · filed 2022-03-31
87.92K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-03-3115.75K shares
10-Q · filed 2021-05-17
81.17K shares
derived: sum of 2 quarters · filed 2022-03-31
81.17K shares
derived: sum of 3 quarters · filed 2022-03-31
83.76K shares
derived: sum of 4 quarters · filed 2022-03-31
2020-12-3165.42K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
65.42K shares
derived: sum of 2 quarters · filed 2022-03-31
68.02K shares
derived: sum of 3 quarters · filed 2022-03-31
73.92K shares
10-K · filed 2022-03-31
2020-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
2.59K shares
derived: sum of 2 quarters · filed 2020-11-13
8.50K shares
10-Q · filed 2020-11-13
28.23K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-06-302.59K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
8.50K shares
10-Q · filed 2020-08-14
28.23K shares
derived: sum of 3 quarters · filed 2021-03-31
32.89K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-03-315.91K shares
10-Q · filed 2020-05-14
25.64K shares
derived: sum of 2 quarters · filed 2021-03-31
30.30K shares
derived: sum of 3 quarters · filed 2021-03-31
32.84K shares
derived: sum of 4 quarters · filed 2021-03-31
2019-12-3119.73K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
24.39K shares
derived: sum of 2 quarters · filed 2021-03-31
26.93K shares
derived: sum of 3 quarters · filed 2021-03-31
29.89K shares
10-K · filed 2021-03-31
2019-09-304.66K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
7.21K shares
derived: sum of 2 quarters · filed 2019-11-12
10.16K shares
10-Q · filed 2019-11-12
10.16K shares
derived: sum of 4 quarters · filed 2020-03-09
2019-06-302.54K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
5.50K shares
10-Q · filed 2019-08-14
5.50K shares
derived: sum of 3 quarters · filed 2020-03-09
5.51K shares
derived: sum of 4 quarters · filed 2020-03-09
2019-03-312.95K shares
10-Q · filed 2019-05-15
2.96K shares
derived: sum of 2 quarters · filed 2020-03-09
2.97K shares
derived: sum of 3 quarters · filed 2020-03-09
2018-12-313.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
16.00 shares
derived: sum of 2 quarters · filed 2020-03-09
44.57K shares
10-K · filed 2020-03-09
2018-09-3013.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
44.57K shares
10-Q · filed 2018-11-13
2018-06-3044.56K shares
10-Q · filed 2018-08-14
2017-12-3116.64K shares
10-K · filed 2019-03-13